MARATTO

article · Expert Review of Anticancer Therapy

Efficacy of doxorubicin and lipiodol therapy by trans-arterial chemoembolization in hepatocellular carcinoma Egyptian patients and relation to genetic polymorphisms

20243 citationsAin Shams University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The trial is registered at ClinicalTrials.gov (CT.gov identifier: NCT05291338).

Research topics

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/14737140.2024.2391364

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.